Introduction
============

Breast cancer is the most prevalent cancer type in females worldwide. According to the GLOBOCAN report, about 2.08 million new breast cancer cases were diagnosed in 2018, accounting for 24.2% of all cancer cases. It is the leading cause of mortality, contributing to 15% of total cancer deaths specifically in less developed countries.[@b1-cmar-11-1087] Previous studies have also endorsed that the incidence of breast cancer is higher in developed counteries.[@b2-cmar-11-1087],[@b3-cmar-11-1087] However, recent evidence suggests that there has been an alarming increase in both incidence and mortality rate in low- and middle-income countries.[@b1-cmar-11-1087],[@b4-cmar-11-1087]--[@b10-cmar-11-1087] This may be due to different factors, such as educational level, lack of awareness and knowledge about the disease and its symptoms, and the unavailability of mammography facilities and breast cancer screening programs in a country; and the prevalence of risk factors such as precancerous lesions, reproductive factors (eg, age at menarche and childbirth, lack of breastfeeding and late menopause), family history, obesity, inappropriate dietary habits, hormonal therapy, physical inactivity, use of oral contraceptives, alcohol consumption, genetic predisposition, exposure to ionizing radiation, change in immune status and host vulnerability.[@b11-cmar-11-1087]--[@b13-cmar-11-1087]

In Pakistan, breast cancer is more common in young females, in contrast to the West, where it occurs after the age of 60 years, on average.[@b14-cmar-11-1087] The age-related incidence rate of breast cancer affecting Pakistani females is almost 50.1/100,000 per year.[@b15-cmar-11-1087] The probability is that one out of every nine Pakistani women will develop breast cancer during her lifetime.[@b16-cmar-11-1087] Pakistan has the highest incidence and mortality rates of breast cancer, with incidence and mortality rates \>5.2 times and \>2.8 times higher, respectively, than the rates within the rest of Asia. Moreover, when compared with neighboring countries, ie, India and Iran, the incidence rate was \>2.5 times higher in Pakistan.[@b5-cmar-11-1087],[@b17-cmar-11-1087] The lack of a national cancer registry in Pakistan is the main reason of low quality incidence, mortality and prevalence data for the country. According to facility- based studies and projections, the number of new cases is estimated between 34,038 and 90,000 cases and mortality around 16,232 deaths in 2017.[@b8-cmar-11-1087],[@b19-cmar-11-1087]

The literature has suggested that a lack of awareness and knowledge is associated with delayed presentation, and this delay may be attributed to personal, sociocultural and economic factors.[@b17-cmar-11-1087],[@b20-cmar-11-1087] Although personal factors such as age, marital status and medical history, along with economic factors such as occupation, monthly income and treatment cost, are not amendable, socio-cultural variables such as people's knowledge and assumptions about a disease, its signs and symptoms, and the perceived stigma associated with the disease, eg, that it is incurable and life-threatening, are adaptable.[@b21-cmar-11-1087] Procrastination results in an enlarged tumor size, advanced stage of disease and poorer prognosis, which ultimately contribute toward increasing morbidity, disability and mortality. Patients with delayed presentation have lower 5-year survival rates than those with early presentation, at 12% and 88%, respectively.[@b22-cmar-11-1087]

In Pakistan, more than 50% of patients present at an advanced stage of disease, ie, stage III or IV.[@b23-cmar-11-1087] The duration of delay in seeking medical aid after the appearance of breast cancer symptoms can be reduced by identifying possible factors contributing to the delay, which could improve early diagnosis of the disease, at a less advanced stage, meaning a better prognosis and ultimately improved survival rates.[@b24-cmar-11-1087]

Material and methods
====================

Study setting
-------------

This study was conducted at the Punjab Institute of Nuclear Medicine (PINUM) Cancer Hospital, Faisalabad, Punjab, Pakistan. Faisalabad, an industrial hub, is the third most populous city of Pakistan, with an approximate population of more than 7.8 million (7,874,790), as indicated by the 2017 census.[@b25-cmar-11-1087] PINUM is a tertiary cancer hospital, established by the Pakistan Atomic Energy Commission (PAEC), that has served the people of Faisalabad and its periphery since 1996. It has well-reputed diagnostic laboratories, along with chemotherapy and radiotherapy facilities for various cancers. For early detection, the outpatient department (OPD) has recently started a breast cancer clinic day program, along with mammography, ultrasound and biopsy facilities. According to the hospital records, about 1,624 breast cancer patients were diagnosed in the OPD from 2011 to 2016.

Sample size
-----------

The minimum sample size, calculated through the Raosoft^®^sample-size calculator, was 111 breast cancer patients.[@b26-cmar-11-1087] The population was taken as 331 (maximum number of patients diagnosed in 2015, according to hospital records). For this, the power was taken as 80%, with a 50% response distribution with 90--95% CI and 5--10% of alpha margin, respectively. $$n = N\frac{x}{\left( {N - 1} \right)E^{2} + x}$$where *N* is population size, *x* is the confidence interval and *E* is the alpha error. With an added 12% contingency for non-response and inappropriate responses, the final sample was calculated to be 125 patients. This sample size was confirmed using G\*Power version 3.1.9.2 (Düsseldorf, Germany). The *F* test (multivariate analysis of variance special effects and interaction) was performed by considering a power of 80% and 0.05 margin of error.[@b27-cmar-11-1087]

Identification of participants
------------------------------

All registered women with breast cancer from January 2011 were consecutively invited to participate in this study. The population sample included patients who were diagnosed, received chemotherapy or visited PINUM cancer hospital for either follow-up or consultation up to April 2017. None of the patients was pregnant or lactating. All consenting patients, regardless of their age and marital status, along with histopathological reports that confirmed the presence of disease, were included in the study. Females with no histological evidence of invasive breast cancer, or who had psychiatric comorbidities impairing their personal ability, amnesia, noncancerous lumps or uncooperative behavior, and those who have not given written consent for their participation, were excluded from the study. Exclusion and inclusion criteria are summarized in [Figure 1](#f1-cmar-11-1087){ref-type="fig"}.

Data collection
---------------

A questionnaire with instructions for data collection and orientation about the study design, in the local language (ie, Urdu or Punjabi), was given to patients, after which they were invited to participate in the study. A semi-structured, face-to-face interview was carried out with each patient, which lasted for 30--40 minutes (mean 26 minutes) per session. The interview included questions on demographic factors, including age, educational and income level, family history of cancer or breast cancer, etc. The patients were also asked to specify the first presenting or observed symptoms of the disease (ie, painless lump, breast pain, etc). Knowledge about breast cancer risk factors was assessed by asking open-ended questions, while possible reasons for their delayed presentation were also documented. In addition, histopathological reports were examined to confirm the diagnosis of invasive disease, along with receptor status and stage of cancer. A univocal numeric identifier for anonymization was assigned to each study participant for data analysis.

Statistical analysis
--------------------

Descriptive and chi-squared tests were performed to determine statistical significance between the studied variables, while logistic regression was used to find associations between the studied variables and delayed presentation. A *P*-value of \<0.05 was considered significant for all tests. Statistical analyses were conducted using SPSS software version 23 (IBM Corporation, Armonk, NY, USA).

Ethical considerations
----------------------

The study design and questionnaire were evaluated and approved by the institutional ethical review committee board of the National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad, Punjab (reference number 102/14). The whole study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from each patient to access her medical records, blood sampling for genotype analysis and authorization to use her personal/genomic data for publication.

Results
=======

Selection of participants
-------------------------

Overall, 200 patients were interviewed during the study period and 75 patients were excluded from the study based on exclusion criteria, ie, missing medical records (n=15), having metastatic carcinoma (n=15), presence of non-cancerous lumps (n=12), unavailability of tissue sample or blocks (n=5), amnesia (n=10), refusal to sign the consent owing to privacy concerns (n=9), incomplete responses to questions (n=5) and refusal to participate at any stage of the interview (n=4), as summarized in [Figure 1](#f1-cmar-11-1087){ref-type="fig"}. Finally, data from 125 patients were analyzed and are presented in this study.

Participants' characteristics
-----------------------------

The mean age of the participants was 44.1±9.91 years, with a range of 24--75 years. The majority were aged more than 40 years (65.6%), had less than 8 years of education (60.8%), and married (99.2%), and 84 patients (67.2%) had poor socioeconomic status (\<Pakistani rupee 5,000/month). Eighty-one patients (64.8%) had a negative family history of cancer while 37 (29.6%) had a positive family history of breast cancer. Fifty-one patients (41%) presented with stage II cancer and 74 (59%) presented at an advanced stage of the disease i.e. III and IV ([Table 1](#t1-cmar-11-1087){ref-type="table"}).

Presenting symptoms
-------------------

[Table 2](#t2-cmar-11-1087){ref-type="table"} shows the initial breast cancer symptoms experienced by patients before they sought any medical help. Patients often presented with more than one symptom; the most common clinical symptom was the presence of a painless breast lump (in 81.1%), with variable localities such as a knot in the armpit (4.2%) and painful breast lumps (2.8%). Four women (3.2%) had complained of nipple discharge or a change in the shape of their breast. Only 2.1% women complained about redness or swelling of the breast skin, such as a peau d'orange modification or mastitis-like onset.

Presentation delay
------------------

Only 14 patients (11.2%) had consulted a doctor within 3 months of developing breast cancer symptoms, while 111 patients (89.8%) had approached the physician after more than 3 months. Out of these 111, 22 patients (17.6%) had sought help from a doctor within 6 months, 48 (38.4%) had consulted within 12 months and the remaining 41 (32.8%) had consulted more than 12 months after the appearance of symptoms. The numbers of patients with each duration of delay in consultation are shown in [Figure 2](#f2-cmar-11-1087){ref-type="fig"}.

Knowledge about risk factors of breast cancer
---------------------------------------------

[Table 3](#t3-cmar-11-1087){ref-type="table"} summarizes the patients' knowledge regarding the breast cancer risk factors. Our patients scored 4.5 out of a maximum score of 17. One-hundred (80%), 92 (73.6%) and 84 patients (67.2%) did not know that parity age, early menarche and late menopause, respectively, are associated with breast cancer. In addition, 76 patients (60.8%) considered breastfeeding as a risk factor for breast cancer. They also failed to identify most of the risk factors, ie, previous breast cancer, obesity, smoking, drinking, oral contraceptives and gender.

Reasons for late presentation
-----------------------------

The reasons given by participants for delayed presentation were as follows: in 107 patients (96%), presentation delay was due to ignorance of disease or the presence of a painless lump in the breast; 90 patients (81%) reported a fear of the cost of anticipated treatment; 81 (73%) informed us that they were shy about being attended by a male doctor and 79 (71%) presented late because of the prior use of herbal or unconventional treatments. Seventy-two participants (65%) were scared about cancer-associated stigma, or isolation from their husband, family and friends, or felt hesitant about undergoing surgical procedures, 68 (61%) had consulted spiritual healers or believed themselves to have been spiritually healed, and 41 (37%) presented late owing to other reasons (eg, "clinic/hospital was too far away", "too busy" or "didn't want anyone to know that I had a lump"). These proportions were not mutually exclusive, as represented in [Figure 3](#f3-cmar-11-1087){ref-type="fig"}.

Factors associated with presentation delay
------------------------------------------

Non-significant associations were observed between the studied variables and patient delay, including the age at diagnosis, menopausal status, tumor location, and positive family history of cancer and breast cancer. Educational status and residential status were significantly (*P*\<0.001) associated with delayed presentation. Delayed presentation due to the women's marital and economic status was also significant (*P*\<0.05), as summarized in [Table 4](#t4-cmar-11-1087){ref-type="table"}. Binary regression confirmed the association between presentation delay and educational level, with an OR of 4.682 (*P*\<0.001). Similar results were obtained for the economic status of patients and presentation delay (OR 1.875, 95% CI 59.006--1.875; *P*=0.007). No association was found for other variables, ie, patient age, residence, positive family history of cancer or breast cancer, menopausal status and tumor location ([Table 5](#t5-cmar-11-1087){ref-type="table"}).

Discussion
==========

Our results have revealed that breast cancer patients are facing major problems in Pakistan in terms of presentation delay that is one of the leading causes of mortality in women. In this study, 88.8% cases of breast cancer presented after a delay (\>3 months) and 93.7% of these women had painless lumps in their breast. The presence of a lump upon examination may indicate a lack of awareness and knowledge about disease symptoms and disease screening programs. This can lead to aggressive disease and ultimately yield lower survival rates. Another study, conducted in a developing country in Middle-East Asia (Jordan), highlighted that 94.7% of asymptomatic patients were diagnosed with breast cancer after a medical examination. Breast cancer due to late presentation has also been shown in other studies.[@b28-cmar-11-1087]--[@b32-cmar-11-1087] All of these outcomes were due to the late presentation, as observed in our study.

We have highlighted several parameters that were responsible for delayed presentation in breast cancer patients. Many variables were identified as being due to a limited level of education, which was a significant factor in the univariate analysis. Most of the Pakistani population has low living standards and they are unable to afford the high educational costs of academic institutes. Moreover, the illiterate population lacks awareness about the disease, its signs and symptoms and its treatment plans. There is an assumption among the public that a person suffering from any sort of carcinoma has zero chance of survival and there is no treatment available for the cancer. So, a lack of awareness and a lack of education are the key factors contributing to late presentation for breast cancer and enhanced mortality.[@b32-cmar-11-1087]--[@b35-cmar-11-1087] In underdeveloped and developing countries, including Pakistan, it is necessary to segregate high-risk patients due to the delayed presentation so that new and implementable strategies can be designed to resolve this issue.

In a prospective, multicenter, cohort study conducted in the USA, among women with recently diagnosed breast cancer of less than 40 years, 17% reported a self-delay associated with poor financial status.[@b36-cmar-11-1087] Paradoxical results have been observed in less affluent societies. In a cross-sectional study conducted in Thailand, 180 women with invasive breast cancer were interviewed about potential risk factors and causes of delayed presentation. The results showed that 17% of delays in seeking consultation for longer than 3 months were associated with higher family income and smoking.[@b37-cmar-11-1087] This may be explained by less attention being paid to health-related problems; nevertheless, this is an example of complex interactions between psychosocial and cognitive factors which cannot be fully explained with simple assumptions.

It was also identified in the present study that breast cancer was more prevalent among married women in the studied population (99.2%). Because of social taboos, women with breast cancer feel embarrassment and shyness when discussing breast-health concerns. Cultural barriers cause married woman to have less access to caregivers and poor orientation towards attending targeted health units alone because they are dependent on their husbands or heads of the family.[@b38-cmar-11-1087] Most of them (72%) rely on alternative medicines for treatment and they habitually skip doses. Thereby, not seeking prompt attention for breast problems and seeking medical care from "quacks", rather than an oncologist, was related to a diagnosis of advanced breast cancer. Moreover, a married woman has a lot of work to do regarding her responsibilities to her family.[@b39-cmar-11-1087]

Most of the Pakistani population lives in rural areas that are lacking in basic necessities such as hospitals, education systems, transport, purified drinking water, hygienic conditions and trained and qualified healthcare providers.[@b24-cmar-11-1087] Therefore, the chances of delayed presentation are higher in rural than in urban populations. Moreover, social norms, poverty, misconceptions, false beliefs about disease, lack of education awareness about the disease and its management may be the leading factors resulting in delayed presentation in this region.[@b40-cmar-11-1087]--[@b45-cmar-11-1087]

In this investigation, 96% of the studied population (n=107) presented with a delay due to a lack of information about symptoms, indicating progression of the disease along with pathological changes in the form of painless lumps. Enlargement of a lump is an alarming indication of cancer, which may prompt a patient to consult a doctor. These factors arise owing to low levels of education, and poor social and economic status.[@b24-cmar-11-1087],[@b40-cmar-11-1087],[@b41-cmar-11-1087],[@b46-cmar-11-1087] Continuously growing lumps, at a slower rate, may grab less attention in the suffering person. In this case, slight delay in presentation can leads to poor recovery. Based on this, one can propose that late-stage tumors and a delayed diagnosis are the predisposing factors associated with the lowest survival chances.[@b47-cmar-11-1087]

In Pakistan, the healthcare system generally focuses on patients, medicines, prescribers and customers, instead of encouraging people to disclose disorders that are symptomatically and asymptomatically progressing, namely raising awareness. This is due to the low levels of routine medical examinations, high consultation fees and lack of counseling time provided by caregivers. Over the past few years, the public health department, cancer hospitals and teaching institutes have initiated an awareness program about breast cancer, supported by national and international non-governmental organizations (NGOs). It aims to counsel the public about consequences, symptomatic profile, risk factors, diagnostic techniques and treatment options. This awareness program is executed via electronic and print media, and seminars organized on world breast cancer day. However, few hospitals have joined the initiative to establish an early-detection service for timely breast cancer diagnosis. These initiatives are running under the name "Breast Clinic Day" in hospitals working under the umbrella of the PAEC. Through these awareness programs, women will be made aware of simple, self-inspection methods to check for tumors, so that they can seek health care as early as possible. The Government of Pakistan health department has a rich resource of personnel including nurses, female medical officers and health visitors, who perform their duties in rural health centers, basic health units, tehsil headquarters, district headquarters and combined military hospitals. Nurses, female medical officers and health visitors are the right choice if training is given and they are used for the stated purpose. This strategy will be a revolutionary step in the early diagnosis of breast cancer in Pakistan. Ultimately, it will improve survival rates and reduce cases of mortality.

Limitations of the study
------------------------

The present study had a small sample size compared to the large number of breast cancer patients in the Pakistani population, and was limited to breast cancer patients who visited PINUM hospital in Faisalabad. Therefore, there may have been a bias in the data related to the regional and background characteristics of the patients. So, similar studies must be conducted in other hospitals in Pakistan to find out the key reasons for delayed presentation. Continual awareness campaigns should be scheduled for awareness in rural as well as urban areas of Pakistan. Minimal charges or free-of-cost screening facilities must be provided by the collaborative action of the Government of Pakistan and other NGOs working nationally or internationally in Pakistan.

Conclusion
==========

A significant percentage of women with breast cancer in Pakistan delay presentation because of their misconceptions and false beliefs about the disease and its management. Failure to understand breast cancer symptoms is a risk factor for delayed presentation. Coordinated efforts are needed from the public health department regarding awareness about breast cancer, its signs and symptoms, risk factors and therapeutic outcomes, to educate the focus groups and remove the barriers identified in the study. Improving symptom recognition to facilitate prompt presentation in this population may improve survival. In the long run, these efforts should result in an increased survival rate and reduced overall burden of the disease in Pakistan.

This study demonstrates the importance of providing interventions and strategies to increase the awareness of breast cancer in Pakistan. One of the roots of the problem is the existence of stigma and financial constraints, representing social and economic barriers to the timely diagnosis and treatment of breast cancer patients. Early diagnosis and early recognition of breast symptoms in primary health care, along with an accessible and affordable referral path for care, can save lives; it is the most powerful and validated way to impact on the population with a reasonable investment in public health. Accordingly, this study has identified the gaps and the possible areas for intervention, providing evidence to build a population-based early diagnosis program to be framed within the national cancer control plan.
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###### 

Sociodemographic data of selected patients and studied variables

  Variable                          Category            Patients (n)   Patients (%)
  --------------------------------- ------------------- -------------- --------------
  Age at diagnosis                  \<40 years          43             34.4
  ≥40 years                         82                  65.6           
  Education                         \<8 years           76             60.8
  ≥8 years                          49                  39.2           
  Marital status                    Married             124            99.2
  Single                            1                   0.8            
  Socioeconomic status              \<PKR 5,000/month   84             67.2
  ≥PKR 5,000/month                  41                  32.8           
  Residence                         Rural               62             49.6
  Urban                             63                  50.4           
  Menopausal status                 Pre-menopausal      70             56
  Post-menopausal                   55                  44             
  Tumor location                    Left breast         63             50.4
  Right breast                      62                  49.6           
  Disease stage                     II                  51             40.8
  III                               73                  58.4           
  IV                                1                   0.8            
  Family history of any cancer      No one              81             64.8
  At least one person               44                  35.2           
  Family history of breast cancer   No one              88             70.4
  At least one person               37                  29.6           

**Abbreviation:** PKR, Pakistani rupee.

###### 

Frequency of patients with presenting symptoms and duration of presentation delay

  Symptom                        Patients, n (%)   Delay \<3 months   Delay ≥3 months
  ------------------------------ ----------------- ------------------ -----------------
  Painless lump in breast        116 (92.8%)       12 (85.7%)         104 (93.7%)
  Lump in armpit                 6 (4.8%)          1 (7.1%)           5 (4.5%)
  Change in breast shape         4 (3.2%)          2 (14.2.1%)        2 (1.8%)
  Nipple discharge               4 (3.2%)          1 (7.1%)           3 (2.7%)
  Painful lump in breast         4 (3.2%)          0 (0%)             4 (3.6%)
  Redness/swelling over breast   3 (2.4%)          1 (7.1%)           2 (1.8%)
  Pain in arm or back            2 (1.6%)          1 (7.1%)           1 (0.9%)
  Bone pain                      2 (1.6%)          0 (0%)             2 (1.8%)
  Ulcer over breast              1 (0.8%)          0 (0%)             1 (0.9%)
  Weakness                       1 (0.8%)          0 (0%)             1 (0.9%)
  Total                          N=125             n=14               n=111

**Note:** Patients often presented with more than one symptom, so column totals do not add up to 100%.

###### 

Assessment of patients' knowledge about breast cancer risk factors

  Risk factor variable     Patients (N=125), n (%)               
  ------------------------ ------------------------- ----------- -----------
  Age                      31 (24.8)                 41 (32.8)   53 (42.4)
  Gender                   34 (27.2)                 29 (23.2)   62 (49.6)
  Early menarche           9 (7.2)                   24 (19.2)   92 (73.6)
  Late menopause           12 (9.6)                  29 (23.2)   84 (67.2)
  Parity age               11 (8.8)                  14 (11.2)   100 (80)
  Trauma                   41 (32.8)                 35 (28)     49 (39.2)
  Stress                   21 (16.8)                 78 (62.4)   26 (20.8)
  Oral contraceptives      38 (30.4)                 16 (12.8)   71 (56.8)
  Obesity                  19 (15.2)                 29 (23.2)   77 (61.6)
  Family history           71 (56.8)                 21 (16.8)   33 (26.4)
  Overweight               33 (26.4)                 31 (24.8)   61 (48.8)
  Breastfeeding            76 (60.8)                 32 (25.6)   17 (13.6)
  Smoking                  41 (32.8)                 20 (16)     64 (51.2)
  Drinking                 42 (33.6)                 21 (16.8)   62 (49.6)
  Pollution                44 (35.2)                 31 (24.8)   50 (40)
  Previous breast cancer   13 (10.4)                 17 (13.6)   95 (76)
  Radiation                30 (24)                   22 (17.6)   73 (58.4)

###### 

Sociodemographic factors and their association with presentation delay

  Variable                          Category            Time of presentation, n (%)   *P*-value[a](#tfn3-cmar-11-1087){ref-type="table-fn"}   
  --------------------------------- ------------------- ----------------------------- ------------------------------------------------------- --------------------------------------------------------
  Age at diagnosis                  \<40 years          4 (9.3%)                      39 (90.7%)                                              0.078
  ≥40 years                         18 (22.0%)          64 (78.0%)                                                                            
  Education                         \<8 years           3 (3.9%)                      73 (96.1%)                                              \<0.001[\*\*](#tfn5-cmar-11-1087){ref-type="table-fn"}
  ≥8 years                          19 (38.8%)          30 (61.2%)                                                                            
  Marital status                    Married             21 (16.9%)                    103 (83.1%)                                             0.03[\*](#tfn4-cmar-11-1087){ref-type="table-fn"}
  Single                            1 (100%)            0 (0%)                                                                                
  Socioeconomic status              \<PKR 5,000/month   19 (22.6%)                    65 (77.4%)                                              0.035[\*](#tfn4-cmar-11-1087){ref-type="table-fn"}
  ≥PKR 5,000/month                  3 (7.3%)            38 (92.7%)                                                                            
  Residence                         Rural               5 (8.1%)                      57 (91.9%)                                              0.005[\*\*](#tfn5-cmar-11-1087){ref-type="table-fn"}
  Urban                             17 (27.0%)          46 (73.0%)                                                                            
  Menopausal status                 Pre-menopausal      13 (18.6%)                    57 (81.4%)                                              0.748
  Post-menopausal                   9 (16.4%)           46 (83.6%)                                                                            
  Tumor location                    Left breast         8 (12.7%)                     55 (87.3%)                                              0.147
  Right breast                      14 (22.6%)          48 (77.4%)                                                                            
  Family history of any cancer      No one              13 (16.0%)                    68 (84.0%)                                              0.537
  At least one person               9 (20.5%)           35 (79.5%)                                                                            
  Family history of breast cancer   No one              16 (18.2%)                    72 (81.8%)                                              0.792
  At least one person               6 (16.2%)           31 (83.8%)                                                                            

**Note:**

Chi-squared test:

*P*≤0.05 and

*P*≤0.001 indicate statistical significance.

**Abbreviation:** PKR, Pakistani rupee.

###### 

Logistic regression analysis showing odds ratios and confidence intervals for the studied variables

  Variable                          Category            Delay in diagnosis, n (%)   Binary analysis                           
  --------------------------------- ------------------- --------------------------- ----------------- ------- --------------- ---------
  Age at diagnosis                  \<40 years          4 (9.3%)                    39 (90.7%)        0.043   0.912--0.043    0.038
  ≥40 years                         18 (22.0%)          64 (78.0%)                                                            
  Education                         \<8 years           3 (3.9%)                    73 (96.1%)        4.682   --              \<0.001
  ≥8 years                          19 (38.8%)          30 (61.2%)                                                            
  Marital status                    Married             21 (16.9%)                  103 (83.1%)       0.000   0.000           1.000
  Single                            1 (100%)            0 (0%)                                                                
  Socioeconomic status              \<PKR 5,000/month   19 (22.6%)                  65 (77.4%)        1.875   59.006--1.875   0.007
  ≥PKR 5,000/month                  3 (7.3%)            38 (92.7%)                                                            
  Residence                         Rural               5 (8.1%)                    57 (91.9%)        0.062   0.701--0.062    0.011
  Urban                             17 (27.0%)          46 (73.0%)                                                            
  Menopausal status                 Pre-menopausal      13 (18.6%)                  57 (81.4%)        0.371   4.909--0.371    0.649
  Post-menopausal                   9 (16.4%)           46 (83.6%)                                                            
  Tumor location                    Left breast         8 (12.7%)                   55 (87.3%)        0.117   1.224--0.117    0.105
  Right breast                      14 (22.6%)          48 (77.4%)                                                            
  Family history of any cancer      No one              13 (16.0%)                  68 (84.0%)        0.028   1.461--0.028    0.113
  At least one person               9 (20.5%)           35 (79.5%)                                                            
  Family history of breast cancer   No one              16 (18.2%)                  72 (81.8%)        0.529   28.095--0.529   0.183
  At least one person               6 (16.2%)           31 (83.8%)                                                            

**Note:** The "--" symbol in the table indicates data not shown due to the low number of patients within \<3 month range for delay in diagnosis.

**Abbreviation:** PKR, Pakistani rupee.
